Loncastuximab (RB4v1.2) 是一种抗 CD19 单克隆抗体 |MedChemExpress (MCE)

CAS：1875032-68-0

品牌：MedChemExpress (MCE)

存储条件：Please store the product under the recommended conditions in the Certificate of Analysis.

生物活性：Loncastuximab (RB4v1.2) 是一种抗 CD19 单克隆抗体。Loncastuximab 展现出抗肿瘤性，在非霍奇金淋巴瘤 (NHL) 包括弥漫性大 B 细胞淋巴瘤 (DLBCL) 中也有潜在的应用。

参考详情： http://www.medchemexpress.cn/loncastuximab.html

参考文献：

[1]. Zinzani PL, et al. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190.

[2]. Hess B, et al. Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma. AAPS J. 2021 Dec 10;24(1):11.